药易购
(300937)
| 流通市值：16.74亿 | | | 总市值：25.45亿 |
| 流通股本：6291.82万 | | | 总股本：9566.67万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 326,254,349.02 | 350,949,875.86 | 386,666,187.5 | 256,667,362.86 |
| 交易性金融资产 | 1,000,000 | - | 1,500,000 | 10,000,000 |
| 应收票据及应收账款 | 351,472,791.94 | 348,590,309.76 | 189,193,526.77 | 423,253,913.11 |
| 其中：应收票据 | - | - | 3,800,000 | 1,957,950 |
| 应收账款 | 351,472,791.94 | 348,590,309.76 | 185,393,526.77 | 421,295,963.11 |
| 应收款项融资 | 25,160,360.43 | 45,534,084.64 | 61,611,545.2 | 23,252,512.62 |
| 预付款项 | 125,949,713.57 | 123,906,967.92 | 131,434,847.01 | 108,547,423.29 |
| 其他应收款合计 | 75,118,650.8 | 71,535,297.01 | 70,801,797.18 | 67,539,904.8 |
| 存货 | 485,897,506.98 | 445,475,079.54 | 516,660,455.06 | 448,001,247.03 |
| 一年内到期的非流动资产 | 11,574,399.27 | 3,270,685.61 | 5,166,592.03 | 5,074,234.99 |
| 其他流动资产 | 26,116,855.86 | 23,049,777.25 | 22,947,966.42 | 33,761,680.74 |
| 流动资产合计 | 1,428,544,627.87 | 1,412,312,077.59 | 1,385,982,917.17 | 1,376,098,279.44 |
| 非流动资产: | | | | |
| 债权投资 | - | 8,054,672.64 | 7,710,153.94 | 7,943,695.67 |
| 长期应收款 | - | 1,063,696 | 1,063,696 | 1,063,696 |
| 长期股权投资 | 28,916,194.95 | 20,515,800.45 | 15,920,375.67 | 15,506,295.47 |
| 其他权益工具投资 | 21,555,964.96 | 21,555,964.96 | 21,555,964.96 | 6,525,964.96 |
| 固定资产 | 137,480,781.3 | 140,389,259.77 | 143,527,242.63 | 144,855,718.98 |
| 在建工程 | 1,917,753.6 | - | 504,424.78 | 2,405,806.83 |
| 使用权资产 | 14,220,448.09 | 17,808,906.19 | 17,319,988.96 | 19,054,296.87 |
| 无形资产 | 44,741,442.69 | 46,355,680.66 | 47,639,359.74 | 48,825,103.6 |
| 开发支出 | 18,852,106.62 | 20,768,328.43 | 19,897,819.83 | 19,611,605.7 |
| 商誉 | 11,571,908.77 | 16,571,059.05 | 16,571,059.05 | 16,571,059.05 |
| 长期待摊费用 | 11,334,740.04 | 11,118,711.95 | 12,856,525.53 | 14,430,716.59 |
| 递延所得税资产 | 29,934,949.71 | 23,563,160.38 | 25,450,106.04 | 21,588,028.63 |
| 其他非流动资产 | 198,000 | 198,000 | 503,933.98 | 305,933.98 |
| 非流动资产合计 | 320,724,290.73 | 327,963,240.48 | 330,520,651.11 | 318,687,922.33 |
| 资产总计 | 1,749,268,918.6 | 1,740,275,318.07 | 1,716,503,568.28 | 1,694,786,201.77 |
| 流动负债: | | | | |
| 短期借款 | 304,046,591.02 | 328,571,591.67 | 372,318,533.77 | 269,083,083.34 |
| 应付票据及应付账款 | 482,853,563.26 | 438,530,635.33 | 332,899,835.59 | 427,678,700.01 |
| 其中：应付票据 | 109,798,817.58 | 126,240,899.26 | 96,626,170.89 | 41,451,733.35 |
| 应付账款 | 373,054,745.68 | 312,289,736.07 | 236,273,664.7 | 386,226,966.66 |
| 合同负债 | 40,864,475.57 | 38,797,379.72 | 49,815,009.32 | 53,024,472.7 |
| 应付职工薪酬 | 11,954,716.38 | 11,424,982.59 | 14,536,566.68 | 11,516,101.62 |
| 应交税费 | 17,110,302.62 | 8,340,868.11 | 16,459,540.7 | 7,678,455.19 |
| 其他应付款合计 | 15,959,615.04 | 16,906,633.91 | 17,615,211.5 | 11,242,396.32 |
| 一年内到期的非流动负债 | 11,182,267.69 | 11,403,501.12 | 14,430,005.77 | 10,714,560.39 |
| 其他流动负债 | 17,412,832.7 | 16,806,708.23 | 19,866,450.57 | 24,889,788.96 |
| 流动负债合计 | 901,384,364.28 | 870,782,300.68 | 837,941,153.9 | 815,827,558.53 |
| 非流动负债: | | | | |
| 租赁负债 | 8,460,259.96 | 10,643,859.12 | 9,760,961.85 | 11,685,925.53 |
| 长期应付款 | 832,976.41 | - | 347,750.04 | 3,195,477.77 |
| 递延收益 | 4,514,439.31 | 4,595,436.74 | 4,676,434.17 | 4,757,431.6 |
| 递延所得税负债 | 14,965,769.56 | 12,267,487.38 | 13,084,272.08 | 13,592,438.35 |
| 非流动负债合计 | 28,773,445.24 | 27,506,783.24 | 27,869,418.14 | 33,231,273.25 |
| 负债合计 | 930,157,809.52 | 898,289,083.92 | 865,810,572.04 | 849,058,831.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 95,666,682 | 95,666,682 | 95,666,682 | 95,666,682 |
| 资本公积 | 474,004,933.25 | 474,004,933.25 | 474,010,205.7 | 474,010,205.7 |
| 盈余公积 | 42,256,512.86 | 42,256,512.86 | 42,256,512.86 | 39,145,368.72 |
| 未分配利润 | 220,422,286.25 | 241,787,077.52 | 237,603,348.1 | 238,248,815.74 |
| 归属于母公司股东权益合计 | 832,350,414.36 | 853,715,205.63 | 849,536,748.66 | 847,071,072.16 |
| 少数股东权益 | -13,239,305.28 | -11,728,971.48 | 1,156,247.58 | -1,343,702.17 |
| 股东权益合计 | 819,111,109.08 | 841,986,234.15 | 850,692,996.24 | 845,727,369.99 |
| 负债和股东权益合计 | 1,749,268,918.6 | 1,740,275,318.07 | 1,716,503,568.28 | 1,694,786,201.77 |
| 公告日期 | 2025-08-12 | 2025-04-25 | 2025-04-11 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |